跳至主要内容
临床试验/NCT05171881
NCT05171881Unknown2 期

Brain Oxygenation in Extremely Preterm Infants-II

Valerie Chock, M.D., M.S. Epi5 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年4月7日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
100
试验地点
5
主要终点
Frequency of interventions used to address cerebral hypoxia

研究概览

简要总结

The Brain Oxygenation-II study (BOx-II) is a phase-II, multicenter, single-arm clinical trial evaluating interventions based on near-infrared spectroscopy (NIRS) monitoring of cerebral oxygen saturation in extremely premature infants. Enrolled infants will follow a treatment guideline to maintain cerebral oxygen saturation in a target range within the first 72 hours of life. The primary outcomes will include interventions used to maintain cerebral saturation in target range, rates of cerebral hypoxia and systemic hypoxia, and a composite of death or severe brain injury detected on term-equivalent magnetic resonance imaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
— 至 6 Hours(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Infants born with postmenstrual age less than 28 weeks
  • •Signed informed consent

排除标准

  • •Missing written parental informed consent
  • •Decision not to conduct full intensive care support
  • •No possibility to place cerebral NIRS oximeter within six hours after birth
  • •Skin integrity insufficient to allow for sensor placement as deemed by a clinician

研究组 & 干预措施

Interventional Arm

Experimental

All infants will undergo non-invasive NIRS monitoring of cerebral oxygen saturation and will have algorithm-driven clinical interventions to maintain cerebral saturation within target range during the first 72 hours of life.

干预措施: Intervention for cerebral hypoxia (Other)

结局指标

主要结局

Frequency of interventions used to address cerebral hypoxia

时间窗: From birth until 72 hours of life

Frequency of specific interventions chosen to address cerebral hypoxia

次要结局

  • Rates of death or severe brain injury(36-42 weeks corrected gestational age)
  • Rates of cerebral hypoxia and systemic hypoxia(From birth until 72 hours of life)

研究者

发起方
Valerie Chock, M.D., M.S. Epi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Valerie Chock, M.D., M.S. Epi

Associate Professor of Pediatrics

Stanford University

研究点 (5)

Loading locations...

相似试验